TERNS PHARMACEUT.DL-0001
Common Stock · EUR · F
430
Price
€44.86
+0.15%
Cap
€5.21B
Earnings
—
30d Trend
-1.5%
430
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range98%
€2.46€45.83
Near 52-week highs — limited upside before resistance
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase…
BRAIN47 SIGNAL
Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.
Running historical backtest...
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.